$MNKD
MANNKIND CORP

2021 Q2 Form 10-Q Financial Statement

#000156459021043433 Filed on August 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $23.28M $15.11M
YoY Change 54.03% 0.75%
Cost Of Revenue $9.926M $3.677M
YoY Change 169.95% -15.02%
Gross Profit $13.35M $11.44M
YoY Change 16.76% 7.14%
Gross Profit Margin 57.36% 75.67%
Selling, General & Admin $20.06M $13.67M
YoY Change 46.72% -17.7%
% of Gross Profit 150.19% 119.52%
Research & Development $2.329M $1.464M
YoY Change 59.08% -10.29%
% of Gross Profit 17.44% 12.8%
Depreciation & Amortization $481.0K $448.0K
YoY Change 7.37% 20.75%
% of Gross Profit 3.6% 3.92%
Operating Expenses $22.38M $15.13M
YoY Change 47.91% -17.03%
Operating Profit -$9.031M -$7.915M
YoY Change 14.1% -27.73%
Interest Expense -$4.058M -$4.300M
YoY Change -5.63% 65.38%
% of Operating Profit
Other Income/Expense, Net -$25.25M -$2.337M
YoY Change 980.45% 62.86%
Pretax Income -$35.52M -$10.25M
YoY Change 246.5% -17.24%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$35.52M -$10.25M
YoY Change 246.5% -17.24%
Net Earnings / Revenue -152.59% -67.83%
Basic Earnings Per Share
Diluted Earnings Per Share -$142.5K -$48.15K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.5M $63.20M
YoY Change 157.11% 92.1%
Cash & Equivalents $62.52M $63.22M
Short-Term Investments $99.97M $0.00
Other Short-Term Assets $3.624M $2.200M
YoY Change 64.73% -72.5%
Inventory $7.482M $3.823M
Prepaid Expenses
Receivables $6.305M $3.366M
Other Receivables $2.101M $0.00
Total Short-Term Assets $179.9M $72.60M
YoY Change 147.8% 45.68%
LONG-TERM ASSETS
Property, Plant & Equipment $28.14M $26.19M
YoY Change 7.45% -3.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $38.95M
YoY Change
Other Assets $5.799M $4.000M
YoY Change 44.98%
Total Long-Term Assets $72.89M $30.20M
YoY Change 141.35% -5.51%
TOTAL ASSETS
Total Short-Term Assets $179.9M $72.60M
Total Long-Term Assets $72.89M $30.20M
Total Assets $252.8M $102.8M
YoY Change 145.91% 25.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.486M $5.800M
YoY Change 29.07% -23.01%
Accrued Expenses $22.41M $14.71M
YoY Change 52.36% -10.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $5.400M
YoY Change -100.0% -40.0%
Long-Term Debt Due $4.873M
YoY Change
Total Short-Term Liabilities $60.43M $67.90M
YoY Change -11.0% -11.79%
LONG-TERM LIABILITIES
Long-Term Debt $280.3M $116.4M
YoY Change 140.77% 27.91%
Other Long-Term Liabilities $5.317M $98.20M
YoY Change -94.59% -10.56%
Total Long-Term Liabilities $5.317M $214.6M
YoY Change -97.52% 6.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.43M $67.90M
Total Long-Term Liabilities $5.317M $214.6M
Total Liabilities $436.3M $282.5M
YoY Change 54.46% 1.69%
SHAREHOLDERS EQUITY
Retained Earnings -$3.100B -$3.000B
YoY Change 3.33% 1.1%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$183.6M -$179.7M
YoY Change
Total Liabilities & Shareholders Equity $252.8M $102.8M
YoY Change 145.91% 25.68%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$35.52M -$10.25M
YoY Change 246.5% -17.24%
Depreciation, Depletion And Amortization $481.0K $448.0K
YoY Change 7.37% 20.75%
Cash From Operating Activities -$21.45M -$3.680M
YoY Change 482.83% -81.35%
INVESTING ACTIVITIES
Capital Expenditures -$1.050M -$150.0K
YoY Change 600.0% -87.7%
Acquisitions
YoY Change
Other Investing Activities -$111.5M $0.00
YoY Change -100.0%
Cash From Investing Activities -$112.5M -$150.0K
YoY Change 74920.0% -89.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -51.49M 28.19M
YoY Change -282.66% -4307.46%
NET CHANGE
Cash From Operating Activities -21.45M -3.680M
Cash From Investing Activities -112.5M -150.0K
Cash From Financing Activities -51.49M 28.19M
Net Change In Cash -185.5M 24.36M
YoY Change -861.38% -211.9%
FREE CASH FLOW
Cash From Operating Activities -$21.45M -$3.680M
Capital Expenditures -$1.050M -$150.0K
Free Cash Flow -$20.40M -$3.530M
YoY Change 477.85% -80.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
mnkd Longterm Purchase Commitment Renewal Time Period
LongtermPurchaseCommitmentRenewalTimePeriod
P2Y
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M
CY2021Q2 mnkd Credit Facility Noncurrent
CreditFacilityNoncurrent
38614000
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
5000000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5317000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
38950000
CY2021Q2 mnkd Paycheck Protection Program Loan Current
PaycheckProtectionProgramLoanCurrent
4873000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
99970000
us-gaap Interest Expense Debt
InterestExpenseDebt
8234000
CY2021Q2 mnkd Gain Loss On Purchase Commitments
GainLossOnPurchaseCommitments
-339000
us-gaap Costs And Expenses
CostsAndExpenses
57180000
us-gaap Investment Income Interest
InvestmentIncomeInterest
28000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
16000
CY2020Q1 mnkd Other Comprehensive Income Loss Write Off Of Cumulative Translation Loss
OtherComprehensiveIncomeLossWriteOffOfCumulativeTranslationLoss
19000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-9322000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-198050000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2185000
CY2021Q1 mnkd Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
397000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
390000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
38000
CY2020Q2 mnkd Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
11600000
CY2020Q2 mnkd Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
117000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
320000
mnkd Gain Loss On Purchase Commitments
GainLossOnPurchaseCommitments
-339000
us-gaap Costs And Expenses
CostsAndExpenses
46385000
us-gaap Operating Income Loss
OperatingIncomeLoss
-16464000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15036000
us-gaap Investment Income Interest
InvestmentIncomeInterest
147000
us-gaap Interest Expense Debt
InterestExpenseDebt
2155000
mnkd Interest Expense Incurred On Promissory Notes
InterestExpenseIncurredOnPromissoryNotes
2540000
CY2020Q1 mnkd Stock Issued During Period Value Debt Interest Payment
StockIssuedDuringPeriodValueDebtInterestPayment
144000
CY2020Q2 mnkd Stock Issued During Period Value Market Price Stock Purchase Plan
StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
14000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10252000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-179710000
mnkd Interest Expense Incurred On Promissory Notes
InterestExpenseIncurredOnPromissoryNotes
1398000
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-22130000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
35000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48439000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
247970000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
212943000
us-gaap Net Income Loss
NetIncomeLoss
-48439000
us-gaap Net Income Loss
NetIncomeLoss
-19574000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12916000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-180419000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2087000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-147000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2509000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
164000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
502000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
202000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-82000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
138920000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1904000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1032000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-173622000
CY2021Q2 mnkd Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
-545000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3926000
CY2021Q2 mnkd Adjustment To Additional Paid In Capital Premium On Convertible Note
AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote
22107000
CY2021Q2 mnkd Stock Issued During Period Value Market Price Stock Purchase Plan
StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
106000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-35523000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-183551000
us-gaap Profit Loss
ProfitLoss
-48439000
us-gaap Profit Loss
ProfitLoss
-19574000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-22130000
us-gaap Share Based Compensation
ShareBasedCompensation
5861000
us-gaap Share Based Compensation
ShareBasedCompensation
3313000
mnkd Interest On Milestone Payment
InterestOnMilestonePayment
3663000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
2935000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-71000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1671000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1105000
mnkd Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
1398000
mnkd Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
2536000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
668000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
576000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1889000
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
496000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-19000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3215000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1343000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-13222000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3803000
mnkd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1554000
mnkd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1401000
mnkd Increase Decrease In Recognized Loss On Purchase Commitments
IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
-3636000
mnkd Increase Decrease In Recognized Loss On Purchase Commitments
IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
-1236000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
5317000
mnkd Increase Decrease In Accrued Interest On Promissory Notes
IncreaseDecreaseInAccruedInterestOnPromissoryNotes
4919000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34178000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14903000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
3000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2030000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
300000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
20000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-143950000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19700000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
230000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7268000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
35051000
mnkd Payment Of Credit Facility Prepayment Penalty
PaymentOfCreditFacilityPrepaymentPenalty
1000000
mnkd Milestone Payments
MilestonePayments
5000000
mnkd Payments Related To Employment Taxes For Share Based Compensation And Proceeds From Exercise Of Stock Options
PaymentsRelatedToEmploymentTaxesForShareBasedCompensationAndProceedsFromExerciseOfStockOptions
148000
mnkd Payments Related To Employment Taxes For Share Based Compensation And Proceeds From Exercise Of Stock Options
PaymentsRelatedToEmploymentTaxesForShareBasedCompensationAndProceedsFromExerciseOfStockOptions
201000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
106000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
14000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11600000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4873000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
173487000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28519000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4641000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33316000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67163000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30222000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
62522000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63538000
us-gaap Interest Paid Net
InterestPaidNet
6717000
us-gaap Interest Paid Net
InterestPaidNet
1820000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1183000
mnkd Issuance Of Common Stock Under Employee Stock Purchase Plan
IssuanceOfCommonStockUnderEmployeeStockPurchasePlan
390000
mnkd Issuance Of Common Stock Under Employee Stock Purchase Plan
IssuanceOfCommonStockUnderEmployeeStockPurchasePlan
318000
mnkd Payment Of Interest On Senior Convertible Notes Through Common Stock Issuance
PaymentOfInterestOnSeniorConvertibleNotesThroughCommonStockIssuance
143000
mnkd Payment Of Interest On Senior Convertible Notes Through Common Stock Issuance
PaymentOfInterestOnSeniorConvertibleNotesThroughCommonStockIssuance
144000
mnkd Payment Of Principal On Senior Convertible Notes Through Common Stock Issuance
PaymentOfPrincipalOnSeniorConvertibleNotesThroughCommonStockIssuance
2630000
mnkd Non Cash Receivable From At The Market Offering
NonCashReceivableFromAtTheMarketOffering
470000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Statement Estimates<span style="font-style:normal;"> — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process and the COVID-19 pandemic has increased the level of judgment used by management in developing these estimates and assumptions. The COVID-19 pandemic continues to rapidly evolve and the ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change. These effects could have a material impact on the estimates and assumptions used in the preparation of the condensed consolidated financial statements. The more significant estimates include revenue recognition and gross-to-net adjustments, assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, milestone rights liability, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets. </span></p>
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62500000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
100000000.0
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
39000000.0
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3100000000
CY2021Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
293300000
CY2021Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
230000000.0
CY2021Q1 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.0250
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62522000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67005000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63222000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
158000
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
316000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
62522000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67163000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63538000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
100000
CY2021Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
100000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0
CY2020Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0
CY2021Q2 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk<span style="font-style:normal;"> — Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market accounts. Investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.</span></p>
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6305000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4218000
mnkd Number Of Wholesale Distributors
NumberOfWholesaleDistributors
3
CY2021Q2 mnkd Percentage Of Sales From Major Customers
PercentageOfSalesFromMajorCustomers
0.82
mnkd Percentage Of Sales From Major Customers
PercentageOfSalesFromMajorCustomers
0.82
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2479000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1393000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3095000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2484000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1908000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1096000
CY2021Q2 us-gaap Inventory Net
InventoryNet
7482000
CY2020Q4 us-gaap Inventory Net
InventoryNet
4973000
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
500000
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2132000
CY2021Q2 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
125457000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
122687000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
97318000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
96820000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28139000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25867000
CY2021Q2 us-gaap Depreciation
Depreciation
481000
CY2020Q2 us-gaap Depreciation
Depreciation
448000
us-gaap Depreciation
Depreciation
941000
us-gaap Depreciation
Depreciation
891000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10318000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11250000
CY2021Q2 mnkd Customer Discounts And Allowances
CustomerDiscountsAndAllowances
4035000
CY2020Q4 mnkd Customer Discounts And Allowances
CustomerDiscountsAndAllowances
3688000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
519000
CY2021Q2 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
1351000
CY2020Q4 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
1422000
CY2021Q2 mnkd Milestone Rights Liabilities Current
MilestoneRightsLiabilitiesCurrent
1088000
CY2020Q4 mnkd Milestone Rights Liabilities Current
MilestoneRightsLiabilitiesCurrent
1337000
CY2021Q2 us-gaap Construction Payable Current
ConstructionPayableCurrent
1055000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
521000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
533000
CY2021Q2 mnkd Sales And Marketing Related Expenses Accrued
SalesAndMarketingRelatedExpensesAccrued
347000
CY2020Q4 mnkd Sales And Marketing Related Expenses Accrued
SalesAndMarketingRelatedExpensesAccrued
99000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1559000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
859000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22406000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19707000
CY2021Q2 mnkd Deferred Social Security Taxes Cares Act
DeferredSocialSecurityTaxesCARESAct
1000000.0
CY2021Q2 us-gaap Senior Notes
SeniorNotes
223217000
CY2021Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
18425000
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
63027000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
285129000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
122235000
mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
146000
mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
179000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
4061000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
812000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6667000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
38425000
CY2021Q2 mnkd Long Term Debt Maturities Repayments Of Principal After Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearThree
243333000
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
293298000
CY2021Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1386000
CY2021Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
6783000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
285129000
CY2021Q2 mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
86000
CY2020Q2 mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
90000
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
363000
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
27000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
488000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
55000
CY2021Q2 mnkd Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
5900000
CY2020Q4 mnkd Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
7300000
CY2021Q2 mnkd Payment For Milestone Rights Liabilities
PaymentForMilestoneRightsLiabilities
5000000.0
CY2021Q2 mnkd Milestone Rights Liability Current
MilestoneRightsLiabilityCurrent
1300000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
100000000.0
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
39000000.0
CY2021Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
100000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
100000
mnkd Market Price Stock Purchase Plan
MarketPriceStockPurchasePlan
25000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-35523000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10252000
us-gaap Net Income Loss
NetIncomeLoss
-48439000
us-gaap Net Income Loss
NetIncomeLoss
-19574000
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
249295000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
213880000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
247970000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
212943000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
72102908000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32845926000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3081203000
us-gaap Variable Lease Cost
VariableLeaseCost
231000
us-gaap Variable Lease Cost
VariableLeaseCost
180000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
370137000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2711066000
CY2021Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
10900000
CY2021Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
14600000
CY2021Q1 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
14600000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
340000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
352000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3313000
CY2021Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
2000000.0
CY2021Q1 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
7000000.0
CY2021Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
5400000
CY2021Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
8500000
CY2021Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
8700000
CY2021Q2 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
15500000
CY2021Q1 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
15500000
CY2021Q2 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
19400000
CY2021Q1 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
19400000
CY2021Q2 mnkd Purchase Obligation Due In Sixth Year
PurchaseObligationDueInSixthYear
9200000
mnkd Long Term Purchase Commitment Expiration Date
LongTermPurchaseCommitmentExpirationDate
2027-12-31
us-gaap Operating Lease Cost
OperatingLeaseCost
685000
us-gaap Operating Lease Cost
OperatingLeaseCost
703000
us-gaap Operating Lease Payments
OperatingLeasePayments
916000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
114000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
79000
us-gaap Operating Lease Payments
OperatingLeasePayments
883000
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.073
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075

Files In Submission

Name View Source Status
0001564590-21-043433-index-headers.html Edgar Link pending
0001564590-21-043433-index.html Edgar Link pending
0001564590-21-043433.txt Edgar Link pending
0001564590-21-043433-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mnkd-10q_20210630.htm Edgar Link pending
mnkd-10q_20210630_htm.xml Edgar Link completed
mnkd-20210630.xsd Edgar Link pending
mnkd-20210630_cal.xml Edgar Link unprocessable
mnkd-20210630_def.xml Edgar Link unprocessable
mnkd-20210630_lab.xml Edgar Link unprocessable
mnkd-20210630_pre.xml Edgar Link unprocessable
mnkd-ex311_9.htm Edgar Link pending
mnkd-ex312_6.htm Edgar Link pending
mnkd-ex321_8.htm Edgar Link pending
mnkd-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending